Ichiro Nakashima

22PUBLICATIONS
61CO-AUTHORS
Neurology and neuromuscular diseasesRheumatology and arthritisPeripheral nervous systemPharmacogenomicsMedical biochemistry - proteins and peptides (incl. medical proteomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Jul 13, 2026
Long-Term Ravulizumab Efficacy and Safety in AQP4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder: Final CHAMPION-NMOSD Results.

|Mar 26, 2026
Headache prevalence and types in multiple sclerosis and related neuroimmunological diseases: A multicenter study.

Hiroki Masuda, Akiyuki Uzawa, Mamoru Shibata

|Feb 24, 2026
Long-term effectiveness and safety of satralizumab for neuromyelitis optica spectrum disorder in a real-world clinical setting in Japan: A 2.5-year final analysis of a multicenter medical chart review (The SAkuraBeyond Study).

Kazuo Fujihara, Noriko Isobe, Katsuichi Miyamoto

|Nov 22, 2025
Differences in the Neural Substrate for Physical and Mental Quality of Life in Patients With Multiple Sclerosis.

Juichi Fujimori, Michiko Nei, Shu Umezawa

|Sep 25, 2025
Safety and Effectiveness of Satralizumab in Japanese Patients with Neuromyelitis Optica Spectrum Disorder: A 30‑Month Interim Analysis of Post‑marketing Surveillance.

Takashi Yamamura, Noriko Isobe, Izumi Kawachi

|Nov 08, 2024
Employment status of multiple sclerosis patients in Japan.

Ichiro Nakashima, Nozomu Tanaka

Pageof 4

Frequent Collaborators

5 joint publications

Noriko Isobe

4 joint publications

Jin Nakahara

3 joint publications

Yusei Miyazaki

3 joint publications

Katsuhisa Yamashita